Interventional device developer BioSphere Medical of Rockland, MA, will launch its proprietary HepaSphere Microspheres, an embolic agent intended for the embolization of liver tumors, in Europe next month.
The product, which has received European Union CE Mark approval, was introduced to European interventional radiologists at the meeting of the Cardiovascular and Interventional Radiological Society of Europe in Nice, France, earlier this month, BioSphere said.
HepaSphere Microspheres will be sold by the firm's direct sales force in France and through its network of distributors in the remaining countries of the European Union.
By AuntMinnie.com staff writers
September 23, 2005
Related Reading
Use of gold loses luster in UAE, May 23, 2004
BioSphere gets FDA clearance for UFE microspheres, November 27, 2002
BioSphere uterine fibroid embolization device comparable to hysterectomy in study, April 9, 2002
Copyright © 2005 AuntMinnie.com
